Trius Therapeutics to Host Analyst and Investor Update Call

Published: Nov 09, 2012

SAN DIEGO, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for life-threatening infections, today announced that it will hold an analyst and investor update call Thursday, November 15, 2012 at 4:15 p.m. Eastern Time (1:15 p.m. Pacific Time). During the call, management will provide commercial and clinical updates for Trius' lead compound, tedizolid phosphate, and Andrew Shorr, MD, MPH from Washington Hospital Center will present his thoughts on the current dynamics in the antibacterial space. The conference call will be webcast live under the Investors section of Trius' website at, where it will be archived for 30 days following the call. Please connect to Trius' website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

Back to news